伯特-霍格-杜布综合征诊断与管理专家共识
伯特-霍格-杜布综合征(BHD)是FLCN基因致病的罕见常染色体显性遗传病,中国人群以肺部囊状病变和气胸为主要表现,肾脏和皮肤受累较欧美少见,漏诊误诊普遍。本共识由多学科专家投票形成15条推荐,涵盖临床评估、诊断标准(根据中国国情修订)、鉴别诊断、治疗、随访和家系管理。核心推荐包括:FLCN基因检测用于确诊、不推荐肺活检作为疑似患者首选、气胸后早期胸膜固定以减少复发、肾肿瘤按直径分层随访(<1 cm每年腹部MR,1-3 cm每6个月MR或消融,>3 cm保留肾功能的局部切除)。共识旨在推动规范诊疗、改善预后,并因有效治疗药物稀缺而建议开展多中心前瞻性临床试验。
要点
- 疑似BHD患者不推荐将肺组织病理活检作为首选,应结合临床表现、基因检测和/或家族史建立诊断。
- BHD合并气胸者推荐早期行胸膜固定术以降低复发风险(43位专家投票,43票赞成)。
- 肾肿瘤按直径分层管理:<1 cm每年腹部MR;1-3 cm每6个月腹部MR或消融手术;>3 cm推荐保留肾功能的肾肿瘤局部切除。
- BHD患者应避免吸烟,并推荐接种流感、肺炎球菌和SARS-CoV-2疫苗以预防感染。
- 发生过气胸的BHD患者,在气胸恢复前不推荐乘坐飞机(43位专家投票,42票赞成,1票弃权)。
适用人群与场景
- 疑似或确诊BHD综合征的患者,临床表现包括弥漫性肺部囊状病变、自发性气胸、皮肤纤维毛囊瘤或毛盘瘤、多种类型肾脏肿瘤。
- BHD综合征患者的家庭成员,其中无症状成人推荐行FLCN基因检测以排除BHD综合征。
- 准备妊娠的BHD综合征夫妇,建议进行产前遗传咨询。
诊断标准与关键阈值
- BHD综合征由第17号染色体p11.2区FLCN基因致病性变异引起,FLCN基因是目前唯一确定的BHD综合征致病基因。
- 临床诊断应基于适当的临床表现,并结合基因检测结果和/或BHD综合征家族史。
- BHD综合征需特别与其他弥漫性囊性肺疾病鉴别,如淋巴管肌瘤病(LAM)、淋巴细胞间质性肺炎(LIP)、肺朗格汉斯细胞组织细胞增生症(PLCH)等。
处置流程与药物剂量
- BHD患者应行胸部CT扫描评估肺部囊状病变,并常规评估肾脏肿瘤病灶,可酌情使用超声、增强CT或MR。
- 基因检测方法包括Sanger测序、多重连接依赖探针扩增(MLPA)和二代测序(NGS),可根据患者个体化医疗需求选择。
- BHD患者应避免吸烟,并推荐接种流感、肺炎球菌和SARS-CoV-2疫苗以预防感染。
- BHD患者合并气胸时推荐早期行胸膜固定术以降低复发风险;发生过气胸者在气胸恢复前不推荐乘坐飞机。
- BHD合并肾肿瘤:肿瘤直径<1 cm时推荐每年腹部MR检查;直径1-3 cm时推荐每6个月腹部MR检查或消融手术;直径>3 cm时推荐保留肾功能的肾肿瘤局部切除。
- BHD患者终身推荐常规肾癌筛查;合并纤维毛囊瘤或毛盘瘤者可选择观察或局部治疗。
- BHD患者夫妇在准备妊娠时建议进行产前遗传咨询,与产前诊断医师共同评估遗传风险,并在妊娠期间讨论产前诊断的可行性。
- BHD患者家族成员应接受健康教育,无症状成人推荐行FLCN基因检测以及时排除BHD综合征。
红旗征与不能漏的情况
- BHD患者发生自发性气胸,需及时处理并考虑早期胸膜固定以降低复发风险。
- BHD患者肾脏肿瘤风险显著增加,需终身常规筛查肾癌,避免漏诊。
研究设计与关键结果
- 本共识由多学科专家制定,通过投票形成15条推荐意见,涉及临床评估、诊断、鉴别诊断、治疗、随访和家系管理,并根据中国国情修订了诊断标准。
- 推荐1:FLCN基因是目前唯一确定的BHD综合征致病基因,家系成员样本基因检测的系谱分析有助于快速识别致病基因变异;基因检测方法包括Sanger测序、MLPA和NGS,可根据患者个体化医疗需求选择(43位专家投票,43票赞成,0票反对,0票弃权)。
- 推荐2:BHD患者应行胸部CT评估肺部囊状病变,并常规评估肾脏肿瘤病灶,可酌情使用超声、增强CT或MR(43位专家投票,43票赞成,0票反对,0票弃权)。
- 推荐3:临床医生应基于适当的临床表现,结合基因检测结果和/或BHD综合征家族史建立诊断(43位专家投票,43票赞成,0票反对,0票弃权)。
- 推荐4:基于临床表现和肺部影像学表现疑似BHD综合征的患者,不推荐将肺组织病理活检作为首选(43位专家投票,43票赞成,0票反对,0票弃权)。
- 推荐5:BHD综合征需特别与其他弥漫性囊性肺疾病鉴别,如淋巴管肌瘤病(LAM)、淋巴细胞间质性肺炎(LIP)、肺朗格汉斯细胞组织细胞增生症(PLCH)等(43位专家投票,43票赞成,0票反对,0票弃权)。
- 推荐6:BHD综合征临床罕见且常涉及多学科(如呼吸与危重症医学、放射科、病理科、胸外科、泌尿外科、遗传学、皮肤科),推荐多学科讨论以提高诊断水平(43位专家投票,43票赞成,0票反对,0票弃权)。
- 推荐7:BHD患者应避免吸烟,并推荐接种流感、肺炎球菌和SARS-CoV-2疫苗以预防感染(43位专家投票,43票赞成,0票反对,0票弃权)。
证据类型、等级与局限
- 证据类型:专家共识,由全国相关领域专家投票形成15条推荐意见,投票结果逐条列出。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对疑似BHD综合征患者,不将肺组织病理活检作为首选,应优先结合临床表现、基因检测和/或家族史诊断,避免有创检查。
- BHD患者合并气胸时,推荐早期胸膜固定以降低复发风险;气胸未恢复前不推荐乘坐飞机。
- BHD患者需终身筛查肾癌,并按肾肿瘤直径分层随访(<1 cm每年腹部MR;1-3 cm每6个月MR或消融;>3 cm保留肾功能的局部切除)。
- BHD患者应避免吸烟并接种流感、肺炎球菌和SARS-CoV-2疫苗以预防感染。
- 推荐对BHD患者无症状成人家庭成员行FLCN基因检测以及时排除BHD综合征,并开展家系健康教育。
指南或共识出处
- 伯特-霍格-杜布综合征诊断与管理专家共识(Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome),发表于中华结核和呼吸杂志(Zhonghua Jie He He Hu Xi Za Zhi)。
提炼说明
- 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder characterized by diffuse pulmonary cysts often leading to recurrent spontaneous pneumothorax, cutaneous fibrofolliculomas or trichodiscomas, and a variety of renal cell cancers. It is caused by pathogenic variants in the FLCN gene located on chromosome 17p11.2. Although an increasing number of patients with BHD syndrome are being recognized in China, the missed diagnosis and delayed diagnosis are still common. In addition, appropriate management is difficult for most of them. Pulmonary cysts and pneumothorax are the main presenting features, but skin and renal lesions appear to be less common in Chinese subjects than those reported from European and American countries. Therefore, the consensus is established by experts from the related disciplines to improve the diagnosis and management of BHD syndrome. This consensus consists of 15 recommendations related to BHD syndrome, including clinical assessments, diagnosis, differential diagnosis, treatment, follow-up, and family management. In particular, it provides revised diagnostic criteria based on the Chinese situation. We hope to promote scientific and clinical progress in this rare disease and improve the prognosis of the patients.Summary of recommendations[Recommendation 1] The folliculin (FLCN) gene is currently the only affirmative causative gene for Birt-Hogg-Dubé (BHD) syndrome, and the pedigree analysis of genetic testing of family members' samples can assist in the rapid identification of causative gene variants. The genetic testing methods, including Sanger sequencing, Multiplex Ligation-dependent Probe Amplification (MLPA), and Next-Generation Sequencing (NGS), can be chosen based on individual patient's care needs. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 2] Patients with BHD syndrome should undergo chest CT scan to evaluate cystic lesions in the lungs, and routine evaluation of the kidneys for tumor foci, using ultrasound, enhanced CT, or MR as appropriate. (43 experts voted; 43 in favor, 0 against, 0 abstention).[Recommendation 3] Clinicians should establish a diagnosis based on the appropriate clinical presentation and in conjunction with genetic test results and/or a family history of BHD syndrome. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 4] Lung histopathological biopsy is not recommended as the first choice for patients with suspected BHD syndrome based on clinical and pulmonary imaging manifestations. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 5] BHD syndrome should be particularly distinguished from other diffuse cystic lung diseases, such as lymphangioleiomyomatosis (LAM), lymphocyte interstitial pneumonia (LIP), pulmonary Langerhans cell histiocytosis (PLCH), etc. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 6] BHD syndrome is clinically rare and often involves multiple disciplines, such as respiratory and critical care medicine, radiology, pathology, thoracic surgery, urology, genetics, and dermatology, and multidisciplinary discussions are recommended to improve the diagnosis of BHD syndrome. (43 voting experts; 43 in favor, 0 against, 0 abstentions).[Recommendation 7] Patients with BHD syndrome should avoid smoking, and are recommended to be vaccinated with influenza, pneumococcal, and SARS-Cov-2 vaccines to prevent infections. (43 voting experts; 43 in favor, 0 against, 0 abstentions).[Recommendation 8] Air travel is not recommended for patients with BHD syndrome who have experienced pneumothorax until it has been recovered. (43 voting experts; 42 in favor, 0 against, 1 abstention).[Recommendation 9] In patients with BHD syndrome complicated by pneumothorax, early pleurodesis is recommended to reduce the risk of recurrence. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 10] Observation or topical treatment may be chosen for patients with BHD syndrome complicated by fibrofolliculoma or trichodiscoma. (43 voting experts; 42 in favor, 0 against, 1 abstention).[Recommendation 11] For patients with BHD syndrome complicated by renal tumors, annual abdominal MR examination is recommended when tumors are <1 cm in diameter; when tumors are 1-3 cm in diameter, abdominal MR examination at every 6 months or ablation surgery is recommended; when renal tumors are >3 cm in diameter, local excision of renal tumors with preservation of renal function is recommended. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 12] Patients with BHD syndrome are associated with significantly increased risks of kidney cancer, and routine screenings of kidney cancer during their lifetime are recommended. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 13] Couples with BHD syndrome are advised to undergo prenatal genetic counseling when preparing for pregnancy, to work with a prenatal diagnostician to assess genetic risk, and to discuss the feasibility of prenatal diagnosis during pregnancy. (43 experts voted; 43 in favor, 0 against, 0 abstention).[Recommendation 14] Family members of patients with BHD syndrome should receive health education, and FLCN gene testing is recommended for asymptomatic adults to rule out BHD syndrome in a timely manner. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 15] Improvements in the clinical diagnosis and treatment of BHD syndrome and overall management are needed. Due to the scarcity of effective therapeutic drugs, multicenter, prospective clinical trials are recommended. (43 experts voted; 43 in favor, 0 against, 0 abstention).
伯特-霍格-杜布综合征(Birt-Hogg-Dubé syndrome,BHD)是一种罕见的常染色体显性遗传性疾病,其临床特征为弥漫性肺部囊状病变、自发性气胸、皮肤纤维毛囊瘤或毛盘瘤和多种类型的肾脏肿瘤。BHD综合征发病机制与第17号染色体的卵泡素蛋白(folliculin,FLCN)相关基因功能丢失变异有关。近年来我国BHD综合征病例报道数量逐年攀升,与欧美高加索人群比较,BHD综合征中国人群多累及肺部,主要呈弥漫性囊状病变并常导致气胸,而肾脏和皮肤受累相对少见,故临床上漏诊和误诊较普遍,缺乏规范诊疗与科学管理。为进一步提高BHD综合征诊治和管理水平,特邀请全国相关领域专家制定本专家共识。本共识通过投票形成15条专家推荐意见,具体包括临床评估、诊断标准、鉴别诊断、治疗、随访以及家系管理等,特别是根据我国实际国情,优化了诊断标准。旨在通过本专家共识,推动BHD综合征规范诊疗和科学研究,改善患者预后。.
参考来源
- [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome]. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 37670643. doi:10.3760/cma.j.cn112147-20230705-00362
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。